Kidney Disease Education Access Expansion Act of 2026
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Overview
The Kidney Disease Education Access Expansion Act of 2026 aims to expand access to kidney disease education services for Medicare and private health insurance beneficiaries. It broadens the definition of who can provide these services, including community health workers, and expands the types of education offered, such as caregiver training and transplant support. The bill also establishes a framework for measuring the effectiveness of these education programs and requires private health insurance plans to cover them.
Key provisions
- Expands the list of qualified providers for kidney disease education services under Medicare.
- Broadens the scope of kidney disease education services to include caregiver training, transplant support, and post-transplant self-care education.
- Increases the number of allowable kidney disease education sessions under Medicare.
- Allows for telehealth delivery of kidney disease education services.
- Establishes a working group to develop methodologies for measuring patient benefit and educational effectiveness.
- Requires the creation of a comprehensive assessment framework to evaluate the success of kidney disease education services.
- Mandates private health insurance plans to cover kidney disease education services.
- Adjusts Medicare payment rules to ensure 100% payment for kidney disease education services.
Who is affected
- Medicare beneficiaries
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
3 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours